EUVIMEDOpdag EUVIMED
Systematische ÜbersichtNetzwerk-Metaanalyse

Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis

Yuanchu Zheng iD, Siming Li, Chen Yang, Zhenwei Yu, Ying Jiang, Tao Feng iD

European Journal of Neurology · 2023-12 · 30 (12) · 3949-3967

DOI: 10.1111/ene.16041 ↗

At a glance

Systematische Übersicht in European Journal of Neurology, published online on 2023-08-28. Written by Yuanchu Zheng and 5 co-authors. Institution: Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Parkinson Disease, Multiple System Atrophy. Cited 44 times so far (Crossref); 81 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Alpha‐synuclein seed amplification assays (α‐syn SAAs) are promising diagnostic methods for Parkinson's disease (PD) and other synucleinopathies. However, there is limited consensus regarding the diagnostic and differential diagnostic performance of α‐syn SAAs on biofluids and peripheral tissues.

Methods

A comprehensive research was performed in PubMed, Web of Science, Embase and Cochrane Library. Meta‐analysis was performed using a random‐effects model. A network meta‐analysis based on an ANOVA model was conducted to compare the relative accuracy of α‐syn SAAs with different specimens.

Results

The pooled sensitivity and specificity of α‐syn SAAs in distinguishing PD from healthy controls or non‐neurodegenerative neurological controls were 0.91 (95% confidence interval [CI] 0.89‐0.92) and 0.95 (95% CI 0.94‐0.96) for cerebrospinal fluid (CSF); 0.91 (95% CI 0.86–0.94) and 0.92 (95% CI 0.87‐0.95) for skin; 0.80 (95% CI 0.66‐0.89) and 0.87 (95% CI 0.69‐0.96) for submandibular gland; 0.44 (95% CI 0.30–0.59) and 0.92 (95% CI 0.79–0.98) for gastrointestinal tract; 0.79 (95% CI 0.70–0.86) and 0.88 (95% CI 0.77–0.95) for saliva; and 0.51 (95% CI 0.39‐0.62) and 0.91 (95% CI 0.84‐0.96) for olfactory mucosa (OM). The pooled sensitivity and specificity were 0.91 (95% CI 0.89–0.93) and 0.50 (95% CI 0.44–0.55) for CSF, 0.92 (95% CI 0.83–0.97) and 0.22 (95% CI 0.06–0.48) for skin, and 0.55 (95% CI 0.42–0.68) and 0.50 (95% CI 0.35–0.65) for OM in distinguishing PD from multiple system atrophy. The pooled sensitivity and specificity were 0.92 (95% CI 0.89–0.94) and 0.84 (95% CI 0.73–0.91) for CSF, 0.92 (95% CI 0.83–0.97) and 0.88 (95% CI 0.64–0.99) for skin and 0.63 (95% CI 0.52‐0.73) and 0.86 (95% CI 0.64‐0.97) for OM in distinguishing PD from progressive supranuclear palsy. The pooled sensitivity and specificity were 0.94 (95% CI 0.90–0.97) and 0.95 (95% CI 0.77–1.00) for CSF and 0.94 (95% CI 0.84–0.99) and 0.86 (95% CI 0.42–1.00) for skin in distinguishing PD from corticobasal degeneration. Conclusions α‐Synuclein SAAs of CSF, skin, saliva, submandibular gland, gastrointestinal tract and OM are promising diagnostic assays for PD, with CSF and skin α‐syn SAAs demonstrating higher diagnostic performance.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseMultiple System AtrophyHumansalpha-SynucleinBiomarkers

Author keywords

Parkinson's diseasebiomarkermeta-analysisseed amplificationspecimen typesα-synuclein

Substances

alpha-SynucleinBiomarkers

Authors and institutions

  • Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Pathophysiology, Beijing Neurosurgical Institute, Beijing, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing, China.

ORCID profiles: Yuanchu Zheng, Tao Feng

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Cite

APA

Zheng, Y., Li, S., Yang, C., Yu, Z., Jiang, Y., & Feng, T. (2023). Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis. European Journal of Neurology, 30(12), 3949-3967. https://doi.org/10.1111/ene.16041

Vancouver

Zheng Y, Li S, Yang C, Yu Z, Jiang Y, Feng T. Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis. European Journal of Neurology. 2023;30(12):3949-3967. doi:10.1111/ene.16041

BibTeX
@article{Zheng2023,
  author = {Zheng, Yuanchu and Li, Siming and Yang, Chen and Yu, Zhenwei and Jiang, Ying and Feng, Tao},
  title = {Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {12},
  pages = {3949--3967},
  doi = {10.1111/ene.16041}
}
Start for free →